Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases
Sponsor: Air Force Military Medical University, China
This observational or N/A phase trial investigates Age-Related Macular Degeneration and Conbercept and is currently ongoing. Air Force Military Medical University, China leads this study, which shows 10 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
-
May 2019 — Nov 2020 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 5 earlier versions
-
Jun 2018 — May 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jun 2017 — Oct 2017 [monthly]
Recruiting NA
First recorded
Feb 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Air Force Military Medical University, China
- Peking University
- Tianjin Medical University
- Xun Xu
- Zhongshan Ophthalmic Center, Sun Yat-sen University
For direct contact, visit the study record on ClinicalTrials.gov .